Stratagems for Breast Cancer Management in the Era of Nanotheranostics – Springer

• Abdull R, Noor N (2013) Cruciferous vegetables: dietary phytochemicals for cancer prevention. Asian Pac J Cancer Prev 14:1565–1570

  Article  Google Scholar 

• Abolzadeh V, Imanparast A, Nassirli H, Tayebi Meybodi N, Khalili Najafabad B, Sazgarnia A (2023) In vivo evaluation of Sono-chemo therapy via hollow gold nanoshells conjugated to mitoxantrone on breast cancer. Iran J Basic Med Sci 26(3):285–294

  PubMed  PubMed Central  Google Scholar 

• Agardan NB, Degim Z, Yilmaz S, AltintaS L, Topal T (2016) The effectiveness of raloxifene loaded liposomes and cochleates in breast cancer therapy. AAPS Pharm SciTech 17(4):968–977

  Article  CAS  Google Scholar 

• Ahn HK, Jung M, Sym SJ, Shin DB, Kang SM, Kyung SY, Park JW, Jeong SH, Cho EK (2014) A phase II trial of Cremorphor EL-free paclitaxel and gemcitabine in patients with advanced non-small cell lung cancer. Cancer Chemother Pharmacol 74(2):277–282

  Article  CAS  PubMed  PubMed Central  Google Scholar 

• Alexander P, Jainamboo M, Praseetha PK, Gopukumar ST (2016) Silica coated liposomes for drug delivery towards breast cancer cells. Rasayan J Chem 9:300–308

  CAS  Google Scholar 

• Alkabban FM, Ferguson T (2022) Breast cancer. In: Stat Pearls. StatPearls Publishing, Treasure Island, FL

  Google Scholar 

• Amioka A, Masumoto N, Gouda N, Kajitani K, Shigematsu H, Emi A, Kadoya T, Okada M (2016) Ability of contrast-enhanced ultrasonography to determine clinical responses of breast cancer to neoadjuvant chemotherapy. Jpn J Clin Oncol 46:303–309

  Article  PubMed  PubMed Central  Google Scholar 

• Anderson BO, Yip CH, Smith RA et al (2008) Guideline implementation for breast healthcare in low-income and middle-income countries: overview of the breast health global initiative global summit 2007. Cancer 113(8):2221–2243

  Article  PubMed  Google Scholar 

• Badea MA, Prodana M, Dinischiotu A, Crihana C, Ionita D, Balas M (2018) Cisplatin loaded multiwalled carbon nanotubes induce resistance in triple negative breast cancer cells. Pharmaceutics 10(4):228

  Article  CAS  PubMed  PubMed Central  Google Scholar 

• Batist G, Ramakrishnan G, Rao CS, Chandrasekharan A, Gutheil J, Guthrie T, Shah P, Khojasteh A, Nair MK, Hoelzer K, Tkaczuk K, Park YC, Lee LW (2001) Reduced cardiotoxicity and preserved antitumor efficacy of liposome-encapsulated doxorubicin and cyclophosphamide compared with conventional doxorubicin and cyclophosphamide in a randomized, multicenter trial of metastatic breast cancer. J Clin Oncol 19(5):1444–1454

  Article  CAS  PubMed  Google Scholar 

• Bennett NC, Farah CS (2014) Next-generation sequencing in clinical oncology: next steps towards clinical validation. Cancers Basel 6:2296–2312

  Article  PubMed  PubMed Central  Google Scholar 

• Berber MR, Elkhenany H, Hafez IH, El-Badawy A, Essawy M, El-Badri N (2020) Efficient tailoring of platinum nanoparticles supported on multiwalled carbon nanotubes for cancer therapy. Nanomedicine 15(08):793–808

  Article  CAS  PubMed  Google Scholar 

• Bollet MA, Racadot S, Rivera S, Arnaud A, Bourgier C (2023) Radiotherapie des cancers du sein : questions dactualite 2023 [breast cancer radiation therapy: current questions in 2023]. Cancer Radiother 27(6–7):524–530

  Article  CAS  PubMed  Google Scholar 

• Breastcancer.org (2023) American Cancer Society: Breast Cancer Facts and Figures 2022–2024, Cancer Facts and Figures https://www.breastcancer.org/facts-statistics

• Brinkman AM, Chen G, Wang Y, Hedman CJ, Sherer NM, Havighurst TC, Gong S, Xu W (2016) Aminoflavone-loaded EGFR-targeted unimolecular micelle nanoparticles exhibit anti-cancer effects in triple negative breast cancer. Biomaterials 101:20–31

  Article  CAS  PubMed  PubMed Central  Google Scholar 

• Bush N, Healey A, Shah A, Box G, Kirkin V, Eccles S, Sontum PC, Kotopoulis S, Kvale S, van Wamel A, Davies CL, Bamber J (2020) Theranostic attributes of acoustic cluster therapy and its use for enhancing the effectiveness of liposomal doxorubicin treatment of human triple negative breast cancer in mice. Front Pharmacol 11:75

  Article  CAS  PubMed  PubMed Central  Google Scholar 

• Cardoso F, Kyriakides S, Ohno S, Penault-Lorca F, Poortmans P, Rubio I, Zackrisson S, Senkus E (2019) Early breast cancer: ESMO clinical practice guidelines for diagnosis, treatment and follow-up. Ann Oncol 30:1194–1220

  Article  CAS  PubMed  Google Scholar 

• Chaurawal N, Misra C, Abul Barkat H, Jatyan R, Chitkara D, Barkat MA, Sharma T, Singh B, Raza K (2022) Oral sorafenib-loaded microemulsion for breast cancer: evidences from the in-vitro evaluations and pharmacokinetic studies. Sci Rep 12(1):13746. https://doi.org/10.1038/s41598-022-17333-6

  Article  CAS  PubMed  PubMed Central  Google Scholar 

• Chen DS, Hurwitz H (2018) Combinations of bevacizumab with cancer immunotherapy. Cancer J 24:193–204

  Article  CAS  PubMed  Google Scholar 

• Chen SH, Liu TI, Chuang CL, Chen HH, Chiang WH, Chiu HC (2020) Alendronate/folic acid-decorated polymeric nanoparticles for hierarchically targetable chemotherapy against bone metastatic breast cancer. J Mater Chem B 8:3789–3800

  Article  CAS  PubMed  Google Scholar 

• Chuba PJ, Hamre MR, Yap J, Severson RK, Lucas D, Shamsa F, Aref A (2005) Bilateral risk for subsequent breast cancer after lobular carcinoma in situ: analysis of surveillance, epidemiology, and end results data. J Clin Oncol 23(24):5534–5541

  Article  PubMed  Google Scholar 

• Clarke M, Collins R, Darby S, Davies C, Elphinstone P, Evans V, Godwin J, Gray R, Hicks C, James S, MacKinnon E, McGale P, McHugh T, Peto R, Taylor C, Wang Y (2005) Effects of radiotherapy and of differences in the extent of surgery for early breast cancer on local recurrence and 15-year survival: an overview of the randomised trials. Lancet 366(9503):2087–2106

  Article  CAS  PubMed  Google Scholar 

• Classe JM, Bordes V, Campion L et al (2009) Sentinel lymph node biopsy after neoadjuvant chemotherapy for advanced breast cancer: results of ganglion Sentinelle et Chimiotherapie Neoadjuvante, a French prospective multicentric study. J Clin Oncol 27(5):726–732

  Article  PubMed  Google Scholar 

• Coleman MP, Quaresma M, Berrino F, Lutz JM, De Angelis R, Capocaccia R, Baili P, Rachet B, Gatta G, Hakulinen T, Micheli A, Sant M, Weir HK, Elwood JM, Tsukuma H, Koifman S, Silva GA, Francisci S, Santaquilani M, Verdecchia A, Storm HH, Young JL (2008) Cancer survival in five continents: a worldwide population-based study. Lancet Oncol 9(8):730–756

  Article  PubMed  Google Scholar 

• Cortes MV, Marchal SA, Blas MP, Mochon JJ, Marchal JA, Martin RM (2020) A versatile theranostic nanodevice based on an orthogonal bioconjugation strategy for efficient targeted treatment and monitoring of triple negative breast cancer. Nanomed Nanotechnol Biol Med 24:102120

  Article  Google Scholar 

• Cui Y, Yang Y, Ma M, Xu Y, Sui J, Li H, Liang J, Sun Y, Fan Y, Zhang X (2019) Reductive responsive micelle overcoming multidrug resistance of breast cancer by co-delivery of DOX and specific antibiotic. J Mater Chem B 7:6075–6086

  Article  CAS  PubMed  Google Scholar 

• Dadgar N, Esfahani MMK, Torabi S, Alavi SE, Akbarzadeh A (2014) Effects of nanoliposomal and pegylated nanoliposomal artemisinin in treatment of breast cancer. Indian J Clin Biochem 29(4):501–504

  Article  CAS  PubMed  Google Scholar 

• Delaney LJ, Ciraku L, Oeffinger BE, Wessner CE, Liu JB, Li J, Nam K, Forsberg F, Leeper DB, O’Kane P, Wheatley MA, Reginato MJ, Eisenbrey JR (2019) Breast cancer brain metastasis response to radiation after microbubble oxygen delivery in a murine model. J Ultrasound Med 38(12):3221–3228

  Article  PubMed  PubMed Central  Google Scholar 

• Draganescu M, Carmocan C (2017) Hormone therapy in breast cancer. Chirurgia 112:413–417

  Article  PubMed  Google Scholar 

• Eisenbrey JR, Shraim R, Liu JB, Li J, Stanczak M, Oeffinger B, Leeper DB, Keith SW, Jablonowski LJ, Forsberg F (2018) Sensitization of hypoxic tumors to radiation therapy using ultrasound-sensitive oxygen microbubbles. Int J Radiat Oncol Biol Phys 101:88–96

  Article  CAS  PubMed  PubMed Central  Google Scholar 

• Friberg S, Nystrom A (2015) Cancer metastases: early dissemination and late recurrences. Cancer Growth Metastasis 8:43–49. https://doi.org/10.4137/CGM.S31244. PMID: 26640389; PMCID: PMC4664198

  Article  PubMed  PubMed Central  Google Scholar 

• Ghafari M, Haghiralsadat F, Pour SKF, Zavar Reza J (2020) Development of a novel liposomal nanoparticle formulation of cisplatin to breast cancer therapy. J Cell Biochem 121(7):3584–3592

  Article  CAS  PubMed  Google Scholar 

• Godavarty A, Rodriguez S, Jung YJ, Gonzalez S (2015) Optical imaging for breast cancer prescreening. Breast Cancer 7:193–209

  PubMed  PubMed Central  Google Scholar 

• Goel H, Sinha VR (2016) P-204 Toxicological and biochemical assessment of specific COX-2 inhibitor as adjuvant in fluoropyrimidine therapy in chemically induced colon cancer. Ann Oncol 27:ii59

  Article  PubMed Central  Google Scholar 

• Goel H, Tikoo K, Karpe PA, Singla R, Sinha VR (2016) Ameliorated chemotherapeutic potential of diverse dose flouropyrimidine therapy by Etodolac via NF-ΚB pathway, PPAR-γ expression and COX-II inhibition in DMH induced colon. Clin Cancer Drugs 3(2):109–120

  Article  CAS  Google Scholar 

• Greenwalt I, Zaza N, Das S, Li BD (2020) Precision medicine and targeted therapies in breast cancer. Surg Oncol Clin N Am 29:51–62

  Article  PubMed  Google Scholar 

• He Y, Zhang L, Song C, Zhu D (2014) Design of multifunctional magnetic iron oxide nanoparticles/mitoxantrone loaded liposomes for both magnetic resonance imaging and targeted cancer therapy. Int J Nanomedicine 9:4055–4066

  Article  PubMed  PubMed Central  Google Scholar 

• Heimes AS, Schmidt M (2018) Atezolizumab for the treatment of triple-negative breast cancer. Exp Opin Investig Drugs 28:1–5

  Article  Google Scholar 

• Hyseni FK, Beijnen JH, Schellens JH (2010) Bevacizumab. Oncologia 15:819–825

  Google Scholar 

• Infante M, Arranz-Ledo M, Lastra E, Olaverri A, Ferreira R, Orozco M, Hernández L, Martínez N, Durán M (2024) Profiling of the genetic features of patients with breast, ovarian, colorectal and extracolonic cancers: association to CHEK2 and PALB2 germline mutations. Clin Chim Acta 552:117695

  Article  CAS  PubMed  Google Scholar 

• Ishii K, Morii N, Yamashiro H (2019) Pertuzumab in the treatment of HER₂ positive breast cancer: an evidence-based review of its safety, efficacy, and place in therapy. Core Evid 14:51–70

  Article  PubMed  PubMed Central  Google Scholar 

• Jablonowski LJ, Conover D, Teraphongphom NT, Wheatley MA (2018) Manipulating multifaceted microbubble Shell composition to target both TRAIL-sensitive and resistant cells. J Biomed Mater Res 106:1903–1915

  Article  CAS  Google Scholar 

• Ji W, Wang B, Fan Q, Xu C, He Y, Chen Y (2017) Chemosensitizing indomethacin-conjugated dextran-based micelles for effective delivery of paclitaxel in resistant breast cancer therapy. PLoS One 12:0180037

  Article  Google Scholar 

• Jones RH, Casbard A, Carucci M, Cox C, Butler R, Alchami F, Madden TA, Bale C, Bezecny P, Joffe J, Moon S, Twelves C, Venkitaraman R, Waters S, Foxley A, Howell SJ (2020) Fulvestrant plus capivasertib versus placebo after relapse or progression on an aromatase inhibitor in metastatic, oestrogen receptor-positive breast cancer: a multicentre, randomised, controlled, phase 2 trial. Lancet Oncol 21(3):345–357

  Article  CAS  PubMed  PubMed Central  Google Scholar 

• Kato K, Chin K, Yoshikawa T, Yamaguchi K, Tsuji Y, Esaki T, Sakai K, Kimura M, Hamaguchi T, Shimada Y, Matsumura Y, Ikeda R (2012) Phase II study of NK105, a paclitaxel-incorporating micellar nanoparticle, for previously treated advanced or recurrent gastric cancer. Investig New Drugs 30(4):1621–1627

  Article  CAS  Google Scholar 

• Kavosi A, Hosseini Ghale Noei S, Madani S, Khalighfard S, Khodayari S, Khodayari H, Mirzaei M, Kalhori MR, Yavarian M, Alizadeh AM, Falahati M (2018) The toxicity and therapeutic effects of single and multiwall carbon nanotubes on mice breast cancer. Sci Rep 8(1):8375

  Article  PubMed  PubMed Central  Google Scholar 

• Kelly LPS, Sun SH, Ren C, Rampersaud IV, Albertson D, Duggan MC, Noel TC, Courtney N, Buteyn NJ, Moritz C, Yu L, Yildiz VO, Butchar JP, Tridandapani S, Rampersaud AA, Carson WE (2021) Antibody conjugation of fluorescent Nanodiamonds for targeted innate immune cell activation. ACS Appl Nano Mater 4(3):3122–3139

  Article  Google Scholar 

• Kesharwani SS, Dachineni R, Bhat GJ, Tummala H (2019) Hydrophobically modified inulin-based micelles: transport mechanisms and drug delivery applications for breast cancer. J Drug Deliv Sci Technol 54:101254

  Article  CAS  Google Scholar 

• Ko NR, Nafiujjaman M, Lee JS, Lim HN, Lee YK, Kwon IK (2017) Graphene quantum dot based theranostic agents for active targeting of breast cancer. RSC Adv 7:11420–11427

  Article  CAS  Google Scholar 

• Kwapisz D (2017) Cyclin-dependent kinase 4/6 inhibitors in breast cancer: Palbociclib, ribociclib, and abemaciclib. Breast Cancer Res Treat 166:41–54

  Article  CAS  PubMed  Google Scholar 

• Lahart IM, Metsios GS, Nevill AM, Carmichael AR (2015) Physical activity, risk of death and recurrence in breast cancer survivors: a systematic review and meta-analysis of epidemiological studies. Acta Oncol 54(5):635–654

  Article  PubMed  Google Scholar 

• Li M, Tang Z, Zhang Y, Lv S, Li Q, Chen X (2015) Targeted delivery of cisplatin by LHRH-peptide conjugated dextran nanoparticles suppresses breast cancer growth and metastasis. Acta Biomater 18:132–143

  Article  CAS  PubMed  Google Scholar 

• Li B, Qi F, Zhu F, Lu Z, Wang M, Chu T, Wu S, Wei J, Song Z, Sukumar S, Zhang C, Xu J, Li S, Nie G (2023) Nanoparticle-based combination therapy enhances Fulvestrant efficacy and overcomes tumor resistance in ER-positive breast cancer. Cancer Res 83(17):2924–2937

  Article  CAS  PubMed  Google Scholar 

• Liao WS, Ho Y, Lin YW, Raj EN, Liu KK, Chen C, Zhou XZ, Lu KP, Chao JI (2019) Targeting EGFR of triple-negative breast cancer enhances the therapeutic efficacy of paclitaxel and cetuximab conjugated nanodiamond nanocomposite. Acta Biomater 86:395–405

  Article  CAS  PubMed  Google Scholar 

• Liu Y, Nguyen N, Colditz GA (2015) Links between alcohol consumption and breast cancer: a look at the evidence. Womens Health 11(1):65–77

  CAS  Google Scholar 

• Liu D, Zhang Q, Wang J, Fan L, Zhu W, Cai D (2019a) Hyaluronic acid-coated single walled carbon nanotubes loaded with doxorubicin for the treatment of breast cancer. Int J Pharm Sci Rev Res 74(2):83–90

  CAS  Google Scholar 

• Liu R, Hu C, Yang Y, Zhang J, Gao H (2019b) Theranostic nanoparticles with tumor-specific enzyme-triggered size reduction and drug release to perform photothermal therapy for breast cancer treatment. Acta Pharm Sin B 9:410–420

  Article  PubMed  Google Scholar 

• Liu J, Chen Z, Li Y, Zhao W, Wu J, Zhang Z (2021) PD-1/PD-L1 checkpoint inhibitors in tumor immunotherapy. Front Pharmacol 12:731798

  Article  CAS  PubMed  PubMed Central  Google Scholar 

• Loibl S, Poortmans P, Morrow M, Denkert C, Curigliano G (2021) Breast cancer. Lancet 397:1750–1769

  Article  CAS  PubMed  Google Scholar 

• Luo X, Wang H, Ji D (2021) Carbon nanotubes loaded ginsenosides Rb3 suppress the PD-1/PD-L1 pathway in triple-negative breast cancer. Aging 13(13):17177

  Article  CAS  PubMed  PubMed Central  Google Scholar 

• Ma M, Zhang X, Hao Y, Liu N, Yin Z, Wang L (2012) A novel lipid based nanomicelle of docetaxel: evaluation of antitumor activity and biodistribution. Int J Nanomedicine 7:3389–3398

  Article  CAS  PubMed  PubMed Central  Google Scholar 

• Ma M, Lei M, Tan X, Tan F, Li N (2016) Theranostic liposomes containing conjugated polymer dots and doxorubicin for bio imaging and targeted therapeutic delivery. RSC Adv 6:1945–1957

  Article  CAS  Google Scholar 

• Maji R, Dey NS, Satapathy BS, Mukherjee B, Mondal S (2014) Preparation and characterization of tamoxifen citrate loaded nanoparticles for breast cancer therapy. Int J Nanomedicine 25(9):3107–3118

  Google Scholar 

• Manaspon C, Pasuwat KV, Pimpha N (2012) Preparation of folate-conjugated Pluronic F127/chitosan Core-Shell nanoparticles encapsulating doxorubicin for breast cancer treatment. J Nanomat 2012:593878

  Article  Google Scholar 

• Martorana F, Motta G, Pavone G, Motta L, Stella S, Vitale SR, Manzella L, Vigneri P (2021) AKT inhibitors: new weapons in the fight against breast cancer. Front Pharmacol 12:662232

  Article  CAS  PubMed  PubMed Central  Google Scholar 

• Maximiano S, Magalhaes P, Guerreiro MP, Morgado M (2016) Trastuzumab in the treatment of breast cancer. BioDrugs 30:75–86

  Article  CAS  PubMed  Google Scholar 

• McCann KE, Goldfarb SB, Traina TA, Regan MM, Vidula N, Kaklamani V (2024) Selection of appropriate biomarkers to monitor effectiveness of ovarian function suppression in pre-menopausal patients with ER+ breast cancer. NPJ. Breast Cancer 10(1):8

  CAS  PubMed  PubMed Central  Google Scholar 

• Mehnati P, Tirtash MJ (2015) Comparative efficacy of four imaging instruments for breast cancer screening. Asian Pac J Cancer Prev 16(15):6177–6186

  Article  PubMed  Google Scholar 

• Miele E, Spinelli GP, Miele E, Tomao F, Tomao S (2009) Albumin-bound formulation of paclitaxel (Abraxane ABI-007) in the treatment of breast cancer. Int J Nanomedicine 4:99–105

  CAS  PubMed  PubMed Central  Google Scholar 

• Mukama T, Fallah M, Brenner H, Xing X, Sundquist K, Sundquist J, Kharazmi E (2020) Risk of invasive breast cancer in relatives of patients with breast carcinoma in situ: a prospective cohort study. BMC Med 18(1):295

  Article  PubMed  PubMed Central  Google Scholar 

• Murthy RK, Loi S, Okines A, Paplomata E, Hamilton E, Hurvitz SA, Lin NU, Borges V, Abramson V, Anders C, Bedard PL, Oliveira M, Jakobsen E, Bachelot T, Shachar SS, Müller V, Braga S, Duhoux FP, Greil R, Cameron D, Carey LA, Curigliano G, Gelmon K, Hortobagyi G, Krop I, Loibl S, Pegram M, Slamon D, Wessels MCP, Walker L, Feng W, Winer EP (2020) Tucatinib, Trastuzumab, and Capecitabine for HER₂ -positive metastatic breast cancer. N Engl J Med 382(7):597–609

  Article  CAS  PubMed  Google Scholar 

• Nguyen X, Hooper M, Borlagdan JP, Palumbo A (2021) A review of fam-Trastuzumab Deruxtecan-nxki in HER₂ positive breast cancer. Ann Pharmacother 55(11):1410–1418

  Article  CAS  PubMed  Google Scholar 

• Nicolini A, Carpi A, Ferrari P, Biava PM, Rossi G (2016) Immunotherapy and hormone-therapy in metastatic breast cancer: a review and an update. Curr Drug Targets 17:1127–1139

  Article  CAS  PubMed  Google Scholar 

• Nie Z, Luo N, Liu J, Zeng X, Zhang Y, Su D (2020) Multi-mode biodegradable tumour microenvironment sensitive nanoparticles for targeted breast cancer imaging. Nanoscale Res Lett 15(1):81

  Article  CAS  PubMed  PubMed Central  Google Scholar 

• Norat T, Scoccianti C, Boutron-Ruault MC, Anderson A, Berrino F, Cecchini M, Espina C, Key T, Leitzmann M, Powers H, Wiseman M, Romieu I (2015) European code against cancer 4th edition: diet and cancer. Cancer Epidemiol 1:S56–S66

  Article  Google Scholar 

• Odeh F, Ismail SI, Dahab RA, Mahmoud IS, Bawab A (2012) Thymoquinone in liposomes: a study of loading efficiency and biological activity towards breast cancer. Drug Deliv 19(8):371–377

  Article  CAS  PubMed  Google Scholar 

• Osborne CK (1998) Tamoxifen in the treatment of breast cancer. N Engl J Med 339:1609–1618

  Article  CAS  PubMed  Google Scholar 

• Ozgen PSO, Atasoy S, Kurt BZ, Durmus Z, Yigit G, Dag A (2020) Glycopolymer decorated multiwalled carbon nanotubes for dual targeted breast cancer therapy. J Mater Chem B 8(15):3123–3137

  Article  Google Scholar 

• Patel HK, Bihani T (2018) Selective estrogen receptor modulators and selective estrogen receptor degraders in cancer treatment. Pharmacol Ther 186:1–24

  Article  CAS  PubMed  Google Scholar 

• Pawar A, Singh S, Rajalakshmi S, Shaikh K, Bothiraja C (2018) Development of fisetin loaded folate functionalized pluronic micelles for breast cancer targeting. Artif Cells Nanomed Biotechnol 46:347–361

  Article  CAS  PubMed  Google Scholar 

• Peng J, Sengupta S, Jordan VC (2009) Potential of selective estrogen receptor modulators as treatments and preventives of breast cancer. Anti Cancer Agents Med Chem 9:481–499

  Article  CAS  Google Scholar 

• Porta C, Paglino C, Mosca A (2014) Targeting PI3K/Akt/mTOR signaling in cancer. Front Oncol 4:64

  Article  PubMed  PubMed Central  Google Scholar 

• Qiu Y, Ren K, Zhao W, Yu Q, Guo R, He J, Mei L, Liu Y, Tang J, Xu S (2021) A dual-guide bioinspired drug delivery strategy of a macrophage based carrier against postoperative triple negative breast cancer recurrence. J Control Release 329:191–204

  Article  CAS  PubMed  Google Scholar 

• Rau KM, Lin YC, Chen YY, Chen JS, Lee KD, Wang CH, Chang HK (2015) Pegylated liposomal doxorubicin combined with cyclophosphamide and 5-fluorouracil is effective and safe as salvage chemotherapy in taxane-treated metastatic breast cancer: an open-label, multi-center, non-comparative phase II study. BMC Cancer 15:423

  Article  PubMed  PubMed Central  Google Scholar 

• Reeder J, Vogel V (2008) Breast cancer prevention. Cancer Treat Res 41:149–164

  Article  Google Scholar 

• Rizzitelli S, Giustetto P, Cutrin J, Castelli DD, Boffa C, Ruzza M, Menchise V, Molinari F, Aime S, Terreno E (2015) Sonosensitive theranostic liposomes for preclinical in vivo MRI-guided visualization of doxorubicin release stimulated by pulsed low intensity non-focused ultrasound. J Control Release 202:21–30

  Article  CAS  PubMed  Google Scholar 

• Rizzitelli S, Giustetto P, Faletto D, Castelli DD, Aime S, Terreno E (2016) The release of doxorubicin from liposomes monitored by MRI and triggered by a combination of US stimuli led to a complete tumor regression in a breast cancer mouse model. J Control Release 230:57–63

  Article  CAS  PubMed  Google Scholar 

• Rockville MD (2002) U.S. preventive services task force. Chemoprevention of breast cancer: recommendations and rationale. Agency for Healthcare Research and Quality. http://www.ahrq.gov/clinic/3rduspstf/breastchemo/breastchemorr.Htm. Accessed 8 Feb 2010

• Rodriguez-Miguel C, Moral R, Escrich R, Vela E, Solanas M, Escrich E (2015) The role of dietary Extra virgin olive oil and corn oil on the alteration of epigenetic patterns in the rat DMBA-induced breast cancer model. PLoS One 10(9):1–16

  Article  Google Scholar 

• Sabatier R, Jauffret EC, Pierga JY, Cure H, Lambaudie E, Genre D, Houvenaeghel G, Viens P, Ginestier C, Bertucci F, Sfumato P, Extra JM, Goncalves A (2019) Stem cells inhibition by bevacizumab in combination with neoadjuvant chemotherapy for breast cancer. J Clin Med 8(5):612

  Article  CAS  PubMed  PubMed Central  Google Scholar 

• Schneble E, Jinga DC, Peoples G (2015) Breast cancer immunotherapy. Maedica 10:185–191

  PubMed  PubMed Central  Google Scholar 

• Schwarz EB, Hoyt-Austin A, Fix M, Kair LR, Iwuagwu C, Chen MJ (2024) Prenatal counseling on the maternal health benefits of lactation: a randomized trial. Breastfeed Med 19(1):52–58

  Article  PubMed  Google Scholar 

• Shah AN, Gradishar WJ (2018) Adjuvant anthracyclines in breast cancer: what is their role. Oncologist 23:1153–1161

  Article  PubMed  PubMed Central  Google Scholar 

• Sheng D, Deng L, Li P, Wang Z, Zhang Q (2021) Perfluorocarbon Nanodroplets with deep tumor penetration and controlled drug delivery for ultrasound/fluorescence imaging guided breast cancer therapy. ACS Biomater Sci Eng 7(2):605–616

  Article  CAS  PubMed  Google Scholar 

• Shirley AJ, Schweeberg S, Waag T, Peindl M, Dandekar G, Walles H, Jakob F, Kruegger A, Ebert R (2021) The influence of differently functionalized nanodiamonds on proliferation, apoptosis and EMT/MET phenomena in 2D and 3D tumor cell cultures. J Mater Chem B 9(45):9395–9405

  Article  CAS  PubMed  Google Scholar 

• Siegel R, Naishadham D, Jemal A (2013) Cancer statistics. CA Cancer J Clin 63:11–30

  Article  PubMed  Google Scholar 

• Siegel RL, Miller KD, Fuchs HE, Jemal A (2021) Cancer statistics. CA Cancer J Clin 71(1):7–33

  Article  PubMed  Google Scholar 

• Singhai NJ, Maheshwari R, Ramteke S (2020) CD44 receptor targeted smart multi walled carbon nanotubes for synergistic therapy of triple negative breast cancer. Colloids Interface Sci Commun 35:100235

  Article  CAS  Google Scholar 

• Sinha VR, Honey (2012a) Critical aspects in rationale design of fluorouracil-based adjuvant therapies for the management of colon cancer. Crit Rev Ther Drug Carrier Syst 29(2):89–148

  Article  CAS  PubMed  Google Scholar 

• Sinha VR, Honey (2012b) Multidimensional role of inulin as synbiotic, drug carrier and synergistic adjuvant for the colonic delivery of 5-FU. Drug Deliv Lett 2(1):60–69

  Article  CAS  Google Scholar 

• Slingerland M, Guchelaar HJ, Rosing H, Scheulen ME, van Warmerdam LJC, Beijnen JH, Gelderblom H (2013) Bioequivalence of liposome-entrapped paclitaxel easy-to-use (LEP-ETU) formulation and paclitaxel in Polyethoxylated Castor oil: a randomized, two-period crossover study in patients with advanced cancer. Clin Ther 35:1946–1954

  Article  CAS  PubMed  Google Scholar 

• Sobczak KD, Wroblewska HP, Klimonda Z, Karwat P, Purska KR, Clauser P, Baltzer PAT, Litniewski J (2021) Multiparametric ultrasound examination for response assessment in breast cancer patients undergoing neoadjuvant therapy. Sci Rep 11:2501

  Article  Google Scholar 

• Sood A, Lang DK, Kaur R, Saini B, Arora S (2021) Relevance of aromatase inhibitors in breast cancer treatment. Curr Top Med Chem 21:1319–1336

  Article  CAS  PubMed  Google Scholar 

• Soyemi TO, Ayandipo OO, Ademola AF, Obajimi GO, Obajimi MO, Ogundiran TO (2018) Role of breast ultrasound in evaluating the response of locally advanced breast cancer to neoadjuvant anthracycline chemotherapy in Ibadan. Glob Surg 4:5–56

  Google Scholar 

• Starek-Świechowicz B, Budziszewska B, Starek A (2023) Alcohol and breast cancer. Pharmacol Rep 75(1):69–84

  Article  PubMed  Google Scholar 

• Stathopoulos GP, Boulikas T (2011) Lipoplatin formulation review article. J Drug Deliv 2012:581363

  PubMed  PubMed Central  Google Scholar 

• Sun JY, Zhang D, Wu S, Xu M, Zhou X, Lu XJ, Ji J (2020) Resistance to PD-1/PD-L1 blockade cancer immunotherapy: mechanisms, predictive factors, and future perspectives. Biomark Res 8:35

  Article  PubMed  PubMed Central  Google Scholar 

• Taran Z, Yektaniroumand Digehsaraei S, Salouti M, Amini B, Mahmazi S, Kalantari M (2023) Methotrexate loaded in alginate beads for controlled drug release against breast cancer. Gene 30(851):146941

  Article  Google Scholar 

• Tarantino P, Morganti S, Curigliano G (2020) Biologic therapy for advanced breast cancer: recent advances and future directions. Exp Opin Biol Ther 20:1009–1024

  Article  CAS  Google Scholar 

• Thavendiranathan P, Shalmon T, Fan CS, Houbois C, Amir E, Thevakumaran Y, Somerset E, Malowany JM, Urzua-Fresno C, Yip P, McIntosh C, Sussman MS, Brezden-Masley C, Yan AT, Koch CA, Spiller N, Abdel-Qadir H, Power C, Hanneman K, Wintersperger BJ (2023) Comprehensive cardiovascular magnetic resonance tissue characterization and cardiotoxicity in women with breast cancer. JAMA Cardiol 8(6):524–534

  Article  PubMed  PubMed Central  Google Scholar 

• Tian Y, Carrillo-Malani N, Feng K, Miller J, Busch TM, Sundaram KM, Cheng Z, Amirshaghaghi A, Tsourkas A (2024) Theranostic Phthalocyanine and Naphthalocyanine nanoparticles for photoacoustic imaging and Photothermal therapy of tumors. Nano 8(1):100–111

  Google Scholar 

• Ueno Y, Sonoda S, Suzuki R, Yokouchi M, Kawasoe Y, Tachibana K, Maruyama K, Sakamoto T, Komiya S (2011) Combination of ultrasound and bubble liposome enhance the effect of doxorubicin and inhibit murine osteosarcoma growth. Cancer Biol Ther 12(4):270–277

  Article  CAS  PubMed  Google Scholar 

• Van der Kolk DM, de Bock GH, Leegte BK, Schaapveld M, Mourits MJ, de Vries J, van der Hout AH, Oosterwijk JC (2010) Penetrance of breast cancer, ovarian cancer and contralateral breast cancer in BRCA1 and BRCA2 families: high cancer incidence at older age. Breast Cancer Res Treat 124(3):643–651

  Article  CAS  PubMed  Google Scholar 

• Wang Y, Wang Y, Chen G, Li Y, Xu W, Gong S (2017) Quantum-dot-based Theranostic micelles conjugated with an anti-EGFR Nanobody for triple-negative breast cancer therapy. ACS Appl Mater Interf 9:30297–30305

  Article  CAS  Google Scholar 

• Wang J, De G, Yue Q, Ma H, Cheng J, Zhu G, Du M, Yi H, Zhao Q, Chen Y (2018) PH responsive polymer micelles enhances inhibitory efficacy on metastasis of murine breast cancer cells. Front Pharmacol 9:543

  Article  PubMed  PubMed Central  Google Scholar 

• Wang B, Jiang T, Huang M, Wang J, Chu Y, Zhong L, Zheng S (2019) Evaluation of the response of breast cancer patients to neoadjuvant chemotherapy by combined contrast-enhanced ultrasonography and ultrasound Elastography. Exp Ther Med 17:3655–3663

  CAS  PubMed  PubMed Central  Google Scholar 

• Wang T, Shang M, Chow KM (2023) Effects of breastfeeding training programmes for midwives on breastfeeding outcomes: a systematic review and meta-analysis. BMC Pregnancy Childbirth 23(1):262

  Article  PubMed  PubMed Central  Google Scholar 

• Weigel S, Heindel W, Heidrich J, Heidinger O, Hense HW (2015) Reduction of advanced breast cancer stages at subsequent participation in mammography. Screening 188(1):33–37

  Google Scholar 

• Willson ML, Burke L, Ferguson T, Ghersi D, Nowak AK, Wilcken N (2019) Taxanes for adjuvant treatment of early breast cancer. Cochrane Database Syst Rev 9:CD004421

  PubMed  Google Scholar 

• World Health Organization (n.d.). https://www.who.int/news-room/fact-sheets/detail/breast-cancer. Accessed 23 Jan 2024

• Xia Y, Deng X, Cao M, Liu S, Zhang X, Xiao X, Shen S, Hu Q, Sheng W (2018) Nanodiamond-based layer-by-layer nanohybrids mediate targeted delivery of miR-34a for triple negative breast cancer therapy. RSC Adv 8(25):13789–13797

  Article  CAS  PubMed  PubMed Central  Google Scholar 

• Yallapu MM, Othman SF, Curtis ET, Bauer NA, Chauhan N, Kumar D, Jaggi M, Chauhan SC (2012) Curcumin loaded magnetic nanoparticles for breast cancer therapeutics and imaging applications. Int J Nanomedicine 7:1761–1779

  CAS  PubMed  PubMed Central  Google Scholar 

• Yang TJ, Ho AY (2013) Radiation therapy in the Management of Breast Cancer. Surg Clin N Am 93:455–471

  Article  PubMed  Google Scholar 

• Yang PJ, Hou MF, Yang F et al (2022) Association of early onset breast cancer with body mass index, menarche, and menopause in Taiwan. BMC Cancer 22(1):259

  Article  CAS  PubMed  PubMed Central  Google Scholar 

• Yu H, Cui Z, Yu P, Guo C, Feng B, Jiang T, Wang S, Yin Q, Zhong D, Yang X (2015) PH- and NIR light-responsive micelles with hyperthermia-triggered tumor penetration and cytoplasm drug release to reverse doxorubicin resistance in breast cancer. Adv Funct Mater 25:2489–2500

  Article  CAS  Google Scholar 

• Zhang C, Xu C, Gao X, Yao Q (2022) Platinum-based drugs for cancer therapy and anti-tumor strategies. Theranostic 12:2115–2132

  Article  Google Scholar 

• Zhao YN, Cao YN, Sun J, Wu Q, Cui SH, Zhi DF, Zhang SB, Liang Z, Zhen YH, Guo ST (2019) Anti-breast cancer activity of resveratrol encapsulated in liposomes. J Mater Chem B 8:27–37

  Article  PubMed  Google Scholar 

• Zheng YR, Suntharalingam K, Johnstone TC, Yoo H, Lin W, Brooks JG, Lippard SJ (2014) Prodrugs designed to bind non-covalently to human serum albumin for drug delivery. J Am Chem Soc 136(24):8790–8798

  Article  CAS  PubMed  PubMed Central  Google Scholar 

• Zhong Y, Zhang J, Cheng R, Deng C, Meng F, Xie F, Zhong Z (2015) Reversibly crosslinked hyaluronic acid nanoparticles for active targeting and intelligent delivery of doxorubicin to drug resistant CD44+ human breast tumor xenografts. J Cont Rel 205:144–154

  Article  CAS  Google Scholar 

Download references